Catalyst Wire Dossier Catalyst Wire Dossier

APG101

· Apogenix GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for APG101, covering 2015-06-16 to 2016-08-24. Get the full timeline:

Most recent: Clinical Trial Update: APG101 in Myelodysplastic Syndrome [Phase 1]

See pricing